Product Information

CAS NO. 868540-17-4 structure
Product Name carfilzomib
Synonyms PR-171
Formula C40H57N5O7
Molecular Weight 719.91
Spec / Purity 99%min
Supply Capacity
Details Carfilzomib is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.The FDA approved it on 20 July 2012 for use in patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy and have demonstrated disease progression on or within 60 days of completion of the last therapy.